- Jane A. LeopoldDivision of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, USAInterests: Cardiovascular disease in women; Microvascular dysfunction; Vascular reactivity; Vascular calcification
Cardiovascular diseases remain the leading cause of morbidity and mortality in women despite advances in prevention, diagnosis, and treatment. Although cardiovascular diseases have been well studied in men, it is now recognized that there are important sex-based differences and not all findings are applicable to women. This has led to a resurgence of interest in identifying contributors to cardiovascular diseases in women as well as guide pharmacotherapeutic and percutaneous or surgical interventions to improve clinical outcomes. This special issue highlights the state-of-the-art in our understanding of cardiovascular diseases in women with a focus on epidemiology and social determinants of cardiovascular health and disease; pregnancy and cardiovascular disease as well as the effect of pregnancy-related complications on future disease; the role of comorbidities on symptoms, presentation, and treatment selection; and sex-based differences in treatment and clinical outcomes of cardiovascular diseases in women. These issues impact chest pain syndromes and coronary artery diseases, valvular heart disease, peripheral artery and cerebrovascular diseases, and pulmonary vascular diseases.
Dr. Jane A. Leopold
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.
- Cardiovascular Events Among Women with Premature Ovarian Insufficiency: A Systematic Review and Meta-AnalysisSamira Behboudi-Gandevani, Ellen Christin Arntzen, Britt Normann, Tommy Haugan, Razieh Bidhendi-YarandiRev. Cardiovasc. Med. 2023, 24(7), 193; https://doi.org/10.31083/j.rcm240719327Downloads101Views
- Reappraising Ischemic Heart Disease in WomenJaclyn Carberry, Louise Aubiniere-Robb, Anna Kamdar, Harriet Lomholt-Welch, Colin BerryRev. Cardiovasc. Med. 2023, 24(4), 118; https://doi.org/10.31083/j.rcm240411854Downloads151Views
- Traditional and Emerging Sex-Specific Risk Factors for Cardiovascular Disease in WomenPuja K. Mehta, Scott Gaignard, Arielle Schwartz, JoAnn E. MansonRev. Cardiovasc. Med. 2022, 23(8), 288; https://doi.org/10.31083/j.rcm2308288184Downloads1Citations446Views
- Sex Differences in the Relationship between New York Heart Association Functional Classification and Survival in Cardiovascular Disease Patients: A Mediation Analysis of Exercise Capacity with Regular Care DataKlaske R. Siegersma, Niels A. Stens, Floor Groepenhoff, Yolande Appelman, ... N. Charlotte Onland-MoretRev. Cardiovasc. Med. 2022, 23(8), 278; https://doi.org/10.31083/j.rcm230827829Downloads206Views
- Anti-Müllerian Hormone and Cardiometabolic Disease in Women: A Two-Sample Mendelian Randomization StudyRenée M.G. Verdiesen, Joanna von Berg, M. Abdullah Said, Pim van der Harst, ... N. Charlotte Onland-MoretRev. Cardiovasc. Med. 2022, 23(8), 269; https://doi.org/10.31083/j.rcm230826920Downloads218Views
- Serum Uric Acid and Hyperuricemia Associate with Coronary Artery Disease among Postmenopausal WomenQianyun Guo, Yang Liu, Xunxun Feng, Jiaqi Yang, ... Yujie ZhouRev. Cardiovasc. Med. 2022, 23(7), 222; https://doi.org/10.31083/j.rcm230722238Downloads133Views
- Review of Lipid-Lowering Therapy in Women from Reproductive to Postmenopausal YearsCeleste Witting, Ankita Devareddy, Fatima RodriguezRev. Cardiovasc. Med. 2022, 23(5), 183; https://doi.org/10.31083/j.rcm230518369Downloads417Views
- Maternal and Neonatal Outcomes in Pregnancy Complicated with Pulmonary HypertensionHua Liao, Qing Hu, Chunyan Deng, Xiaodong Wang, Haiyan YuRev. Cardiovasc. Med. 2022, 23(5), 172; https://doi.org/10.31083/j.rcm230517239Downloads174Views
- Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy–Application of A New Multivariate Predictive Model. The Life StudyAlexander Lilja-Cyron, Casper N. Bang, Eva Gerdts, Anne C. Larstorp, ... Richard B. DevereuxRev. Cardiovasc. Med. 2022, 23(3), 95; https://doi.org/10.31083/j.rcm230309559Downloads2Citations301Views